Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients

被引：48

作者：

Regent, Alexis ^{[1
]}

Redeker, Serge ^{[2
]}

Deroux, Alban ^{[3
]}

Kieffer, Pierre ^{[4
]}

Ly, Kim Heang ^{[5
]}

Dougados, Maxime ^{[6
]}

Liozon, Eric ^{[5
]}

Larroche, Claire ^{[7
]}

Guillevin, Loic ^{[1
]}

Bouillet, Laurence ^{[3
]}

Espitia, Olivier ^{[8
]}

Costedoat-Chalumeau, Nathalie ^{[1
]}

Soubrier, Martin ^{[9
]}

Brihaye, Benoit ^{[10
]}

Lifermann, Francois ^{[11
]}

Lefevre, Guillaume ^{[12
]}

Puechal, Xavier ^{[13
,14
]}

Mouthon, Luc ^{[13
,14
]}

Toussirot, Eric ^{[15
]}

机构：

[1] Univ Paris 05, Hop Cochin, APHP, Ctr Reference Malad Autoimmunes & Syst Rares,Serv, Paris, France

[2] Ctr Hosp Abbeville, Serv Med Interne, Abbeville, France

[3] Univ Grenoble Alpes, Serv Med Interne, CHU Grenoble, Grenoble, France

[4] Ctr Hosp Gen Mulhouse, Serv Med Interne, Mulhouse, France

[5] CHU Limoges, Serv Med Interne, Limoges, France

[6] Univ Paris 05, Hop Cochin, APHP,INSERM,PRES Sorbonne Paris Cite, Clin Epidemiol & Biostat,Dept Rheumatol,U1153, Paris, France

[7] Hop Avicenne, Serv Med Interne, Avicenne, France

[8] Hop Hotel Dieu, Serv Med Interne, Paris, France

[9] CHU Clermont Ferrand, Serv Rhumatol, Clermont Ferrand, France

[10] Hop St Quentin, Serv Med Interne & Med Polyvalente, Paris, France

[11] CH Dax, Serv Med Interne, Dax, France

[12] Hop Claude Huriez, Serv Med Interne, Paris, France

[13] Univ Paris 05, Paris, France

[14] Hop Cochin, APHP, Serv Med Interne, Ctr Reference Malad Autoimmunes & Syst Rares, Paris, France

[15] CHRU, INSERM CIC 1431, FHU INCREASE,Serv Rhumatol, Ctr Invest Clin Biotherapie, Paris, France

来源：

JOURNAL OF RHEUMATOLOGY | 2016年 / 43卷 / 08期

关键词：

GIANT CELL ARTERITIS; TOCILIZUMAB; BIOLOGICAL THERAPY; LARGE-VESSEL VASCULITIS; INTERLEUKIN-6;

D O I：

10.3899/jrheum.151252

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective. To report the efficacy and safety of tocilizumab (TCZ) for giant cell arteritis (GCA). Methods. A retrospective multicenter study that included 34 patients receiving TCZ for GCA. Results. TCZ was effective in all but 6 patients, who still had mild symptoms. Mean glucocorticoid dose was tapered. One patient died and 3 patients had to stop TCZ therapy because of severe adverse events. Twenty-three patients stopped treatment; 8 of these experienced relapses after a mean of 3.5 +/- 1.3 months. Conclusion. TCZ is effective in GCA. However, side effects occur. Whether this treatment has only a suspensive effect remains to be determined.

引用

页码：1547 / 1552

页数：6

共 50 条

[41] Treatment of Giant Cell Arteritis in the ARTESER Multicenter Study of 1675 Patients
Sanchez-Costa, Jesus T.
Hernandez-Rodriguez, Inigo
Fernandez-Fernandez, Elisa
Silva-Diaz, Maria T.
Valero-Jaimes, Jesus A.
Gonzalez-Fernandez, Ismael
Sanchez, Julio
Lluch, Judit
Galindez-Agirregoikoa, Eva
Mendizabal-Mateos, Javier
Bermejo, Pia M. Lois
Loricera, Javier
Munoz, Alejandro
Valero-Martinez, Cristina
Moya, Patricia
Larena-Grijalba, Carmen
Navarro-Angeles, Vanessa A.
Calvet-Fontova, Joan
Casafont, Ivette
Ortiz-Sanjuan, Francisco
Labrada-Arrabal, Selene
Calvo-Alen, Jaime
Iniguez-Ubiaga, Carlota L.
Hernandez, Vanesa
Campos-Fernandez, Cristina
Alcalde-Villar, Maria
Juan-Mas, Antonio
De Miguel, Eugenio
Narvaez, Javier
Angel Gonzalez-Gay, Miguel
Garrido-Punal, Noemi
Estrada-Alarcon, Paula V.
Blanco, Ricardo
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2946 - 2948
[42] TOCILIZUMAB FOR TAKAYASU ARTERITIS: MULTICENTER STUDY OF 54 WHITE PATIENTS
Prieto-Pena, D.
Bernabeu, P.
Vela-Casasempere, P.
Narvaez, J.
Fernandez-Lopez, C.
Freire Gonzalez, M.
Gonzalez-Alvarez, B.
Solans-Laque, R.
Callejas-Rubio, J. L.
Ortego, N.
Fernandez-Diaz, C.
Rubio Romero, E.
Garcia Morillo, S.
Minguez, M.
Fernandez-Carballido, C.
De Miguel, E.
Melchor, S.
Salgado-Perez, E.
Bravo, B.
Romero-Yuste, S.
Salvatierra, J.
Hidalgo, C.
Manrique Arija, S.
Romero-Gomez, C.
Moya, P.
Alvarez-Rivas, N.
Mendizabal, J.
Ortiz Sanjuan, F. M.
Perez de Pedro, I.
Alonso Valdivieso, J. L.
Laura, P. S.
Rosa, R. M.
Fernandez-Llanio, N.
Gomez de la Torre, R.
Suarez, S.
Montesa, M. J.
Delgado Sanchez, M.
Loricera, J.
Atienza-Mateo, B.
Castaneda, S.
Gonzalez-Gay, M. A.
Blanco, R.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1208 - 1209
[43] Tocilizumab in Caucasian Patients with Takayasu Arteritis: Multicenter Study of 54 Patients
Prieto-Pena, Diana
Bernabeu, Pilar
Vela, Paloma
Narvaez, Javier
Carlos Fernandez-Lopez, Jesus
Freire, Mercedes
Gonzalez-Alvarez, Beatriz
Solans-Laque, Roser
Luis Callejas, Jose
Ortego, Norberto
Fernandez-Diaz, Carlos
Rubio Romero, Esteban
Garcia-Morillo, Salvador
Minguez, Mauricio
Carballido, Cristina
De Miguel, Eugenio
Melchor, Sheila
Salgado, Eva
Bravo, Beatriz
Romero-Yuste, Susana
Salvatierra, Juan
Hidalgo, Cristina
Manrique Arija, Sara
Romero Gomez, Carlos
Moya, Patricia
Alvarez-Rivas, Noelia
Mendizabal-Mateos, Javier
Ortiz-Sanjuan, Francisco
Perez De Pedro, Ivan
Alonso-Valdivielso, Jose L.
Perez-Sanchez, Laura
Roldan, Rosa
Fernandez-Llanio, Nagore
Gomez de la Torre, Ricardo
Suarez, Silvia
Montesa Cabrera, Mara Jess
Delgado Sanchez, Monica
Loricera, Javier
Atienza-Mateo, Belen
Angel Gonzalez-Gay, Miguel
Blanco, Ricardo
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3925 - 3927
[44] Tocilizumab for giant cell arteritis: what is optimal?
Kaymakci, M.
Warrington, K. J.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (04) : 777 - 779
[45] Efficacy of tocilizumab in refractory giant cell arteritis
Vinit, Julien
Bielefeld, Philip
Muller, Geraldine
Besancenot, Jean-Francois
JOINT BONE SPINE, 2012, 79 (03) : 317 - 318
[46] Trial of Tocilizumab in Giant-Cell Arteritis
Akiyama, Mitsuhiro
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (15): : 1493 - 1494
[47] Design of the Tocilizumab in Giant Cell Arteritis Trial
Unizony, Sebastian H.
Dasgupta, Bhaskar
Fisheleva, Elena
Rowell, Lucy
Schett, Georg
Spiera, Robert
Zwerina, Jochen
Harari, Olivier
Stone, John H.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2013, 2013
[48] Benchmarking tocilizumab use for giant cell arteritis
Conway, Richard
Putman, Michael S.
Mackie, Sarah L.
RHEUMATOLOGY ADVANCES IN PRACTICE, 2022, 6 (02)
[49] Tocilizumab in giant cell arteritis: an update for the clinician
Ford, Julia A.
Gewurz, Danya
Gewurz-Singer, Ora
CURRENT OPINION IN RHEUMATOLOGY, 2023, 35 (03) : 135 - 140
[50] Tocilizumab for giant cell arteritis: an amazing result
Metin Işık
Levent Kılıç
İsmail Doğan
Meral Çalgüneri
Rheumatology International, 2013, 33 : 2961 - 2962

← 1 2 3 4 5 →